Crossmark

Zingerone treats postmenopausal osteoporosis via increased ferroptosis sensitivity by p53-mediated regulation of SAT1 and GPX4 expression

Published Online: 2025-09-26

Authors

Li, Hao

Cao, Fangming

Liu, Dian

Tao, Lin https://orcid.org/0000-0002-1702-9833
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (22-321-32-08)
License Information

Text and Data Mining valid from 2025-09-26

Version of Record valid from 2025-09-26
More Information

Article History

Received: 2 September 2024

Accepted: 20 August 2025

First Online: 26 September 2025

Competing interests

: The authors declare no competing interests.

Document is current